Teachers Advisors’s Catalyst Pharmaceutical CPRX Stock Holding History

Teachers Advisors’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$1.11M	Hold	218,143	–	–	﹤0.01%	2239
2018 Q4	$419K	Hold	218,143	–	–	﹤0.01%	2586
2018 Q3	$825K	Buy	218,143 +23,321	+12%	+$73.1K	﹤0.01%	2407
2018 Q2	$608K	Buy	194,822 +29,762	+18%	+$90.3K	﹤0.01%	2566
2018 Q1	$394K	Buy	165,060 +38,364	+30%	+$127K	﹤0.01%	2630
2017 Q4	$495K	Hold	126,696	–	–	﹤0.01%	2566
2017 Q3	$319K	Hold	126,696	–	–	﹤0.01%	2796
2017 Q2	$350K	Buy	+126,696	New	+$264K	﹤0.01%	2777
2016 Q2	–	Sell	-110,543	Closed	-$129K	–	3129
2016 Q1	$129K	Hold	110,543	–	–	﹤0.01%	2906
2015 Q4	$271K	Hold	110,543	–	–	﹤0.01%	2747
2015 Q3	$332K	Hold	110,543	–	–	﹤0.01%	2632
2015 Q2	$457K	Buy	+110,543	New	+$441K	﹤0.01%	2579

Other funds holding CPRX

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Teachers Advisors's CPRX Position: Q1 2019 in Review

Teachers Advisors held its Catalyst Pharmaceutical (CPRX) position steady in Q1 2019 at 218,143 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #2239.

Teachers Advisors first reported a position in CPRX in Q2 2015 and has held it in 12 quarters since. 88 funds tracked by Wall St. Rank hold CPRX as of Q1 2019.

Teachers Advisors held 218,143 shares of Catalyst Pharmaceutical worth $1.11M as of Q1 2019.
Teachers Advisors left its Catalyst Pharmaceutical share count unchanged in Q1 2019.
Catalyst Pharmaceutical made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2239 holding.
Teachers Advisors first reported a position in Catalyst Pharmaceutical in Q2 2015 and has held it in 12 quarters since.
88 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.